1. No category

Brain Metastasis
Therapeutics Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Brain metastasis is a type of cancer that usually occurs due to the spread of cancerous
cells to brain. Thus, it is also known as metastatic brain tumor or secondary brain cancer,
while in primary brain cancer the tumor occurs in the brain. Brain metastasis is common
as compared to the primary brain cancer. Brain metastasis is a major complication of
systemic cancer and is one of the major reasons causing morbidity and mortality in
cancer patients. The common type of cancer that spread to the brain are breast cancer,
lung cancer, melanoma, renal cell carcinoma and colon. The cancer may spread to any
part of brain but it is commonly found in the brain cerebrum. Cerebellum and stem cells
are rarely found to be affected by brain metastasis. Brain metastasis may be single tumor
or multiple, although multiple brain metastasis is common. The symptoms associated
with brain metastasis are edema, seizure and severe headache. Therefore the first line of
treatment for brain metastasis is treating the symptoms.
Brain Metastasis Therapeutics Market: Drivers & Restraints
The global brain metastasis therapeutics market is driven by the increasing need of
treatment for symptoms associated with brain metastasis. Also, the chemotherapeutic
agents are known to be the primary tools for cancer treatment which are estimated to
increase the overall brain metastasis therapeutic market. The increased prevalence of
cancer that spread to the brain are also expected to drive the global metastasis
therapeutics market. Though the market seems to be opportunistic in the forecast period
there are some factors such as high cost of treatment and side effects associated with the
chemotherapy are expected to restrain the growth of brain metastasis therapeutics
market.
Report
Description
Report Description
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1360
Brain Metastasis Therapeutics Market: Segmentation
Brain metastasis therapeutics market is segmented on the basis of treatment type, end
user, and region.
Based on treatment, the global brain metastasis therapeutics market is segmented into:
• Radiation therapy
• Chemotherapy
• Targeted therapy
• Anticonvulsants
• Corticosteroids
Based on end use, the global brain metastasis therapeutics market is segmented into the
following:
• Cancer Hospitals
• Clinics
• Cancer Research Centers
Report
Description
Report Description
Brain Metastasis Therapeutics Market: Overview
Chemotherapeutic drugs segment would hold maximum market share in overall brain
metastasis market owing to widespread availability of variety of chemotherapeutic
agents for the brain metastasis cancer treatment. The first line of treatment for brain
metastasis is the treatments of symptoms through anticonvulsants and corticosteroids
thus the market for these segments are expected to grow at faster rate over the forecast
period. According to the American Association of Neurological Surgeons (AANS), in U.S,
every year approximately 170,000 new cases of brain metastasis are diagnosed due to
which the global brain metastasis market is estimated grow during the forecast period.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1360
Brain Metastasis Therapeutics Market: Region-wise Outlook
Depending on geographic regions, global brain metastasis therapeutics market is
segmented into seven key regions: North America, South America, Eastern Europe,
Western Europe, Asia Pacific, Japan, and Middle East & Africa. Geographically, North
America represents the largest regional market for brain metastasis therapeutics owing
to high incidence rate of cancer. North America is followed by Europe and APEJ in terms
of the increasing incidence of cancer. In Asia Pacific and Latin America, the market is
expected to grow due to increase in healthcare awareness, continuously improving
economy leading to increased affordability and relatively less competition as compared
to that of developed regions of North America and Europe.
Report
Description
Report Description
It is also expected that a large percentage of cases which go unnoticed in developing
countries will be recognized with advancing diagnostics and lead to a better market
opportunity for therapeutics in Asia pacific.
Brain Metastasis Therapeutics Market: Key Players
Some of the major companies operating in the development and marketing of brain
metastasis drugs includes Bayer AG, Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd., Eli Lilly
& Company, Novartis AG, GlaxoSmithKline, Merck & Co., Inc., AstraZeneca and
AngioChem Inc.
Browse full report: http://www.futuremarketinsights.com/reports/brain-metastasistherapeutics-market
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705